 CORAL GABLES, Fla. , June 7, 2022 PRNewswire -- Relmada Therapeutics, Inc. NASDAQ: RLMD, a late-stage biotechnology company addressing diseases of the central nervous system CNS, today announced that Sergio Traversa, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on Tuesday, June 14, 2022, at 10:40am PT 1:40pm ET. 